CRAICRA International, Inc.

$199.83+8.7% 1Y

Is the price fair?

Mixed

In its normal P/E range. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 neutral, 2 without data
Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 14.5 vs a 18.4 median over 26 quarters (−22% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CRAI's price assumes

CRA International, Inc. has no trailing P/E on file, so the price is measured against sales instead: 1.19× revenue.

1.19

Price / sales · no trailing P/E on file: measured against sales instead

Price / book
5.20

Price / book · as of 2026-Q2

EV / sales
1.44

EV / sales

Details›
Price / bookas of 2026-Q2
5.20
EV / EBITas of 2026-Q2
14.4
EV / salesas of 2026-Q2
1.44
Market capitalisation6.3 million shares, counted Jul 31, 2026
$1.25B

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.